CASP3 and in situ carcinoma: There was a significant (p < 0.001) decrease in Bcl-2 (Figure 6A,B), an increase in Bax (Figure 6A,C), and cleaved caspase-3 (Figure 6A,D) in the kidney of CIS-administered mice as compared to the control group.